Taken together, our present results suggest that HIF-2α may be a key factor in the maintenance of bone homeostasis, and its regulation may be an important therapeutic target in efforts to address bone fracture and pathological diseases associated with bone loss, including cancer, RA, and osteoporosis. Here, EPAS1 is linked to osteoporosis.